Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans

Although intensive glycemic control improves outcomes in type 1 diabetes mellitus (T1DM), iatrogenic hypoglycemia limits its attainment. Recurrent and/or antecedent hypoglycemia causes blunting of protective counterregulatory responses, known as hypoglycemia-associated autonomic failure (HAAF). To d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes
Auteurs principaux: Carey, Michelle, Gospin, Rebekah, Goyal, Akankasha, Tomuta, Nora, Sandu, Oana, Mbanya, Armand, Lontchi-Yimagou, Eric, Hulkower, Raphael, Shamoon, Harry, Gabriely, Ilan, Hawkins, Meredith
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2017
Sujets:
Metabolism
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652610/
https://ncbi.nlm.nih.gov/pubmed/28860128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db16-1478
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires